Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Conjugate or complex
Patent
1998-01-14
1999-06-15
Scheiner, Laurie
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Conjugate or complex
4241901, 4241921, 4241931, 4241941, 530350, A61K 39385
Patent
active
059119969
ABSTRACT:
A protein derivable from Actinobacillus pleuropneumoniae (APP) having a molecular size ranging between 43 Kd on SDS PAGE is described. The protein is soluble on sodium lauryl sarcosinate (SLS) and not heat modifiable. The protein can also be derived by recombinant methods. The protein in a vaccine provides immunity against multiple serotypes of APP.
REFERENCES:
Mulks, M., and Thacker, B., in Proc. Int. Pig Veter. Soc. 10 81 (1988).
P. J. Fedorka-Cray, M. J. Huether, D. L. Stine, and G. A. Anderson. Effidacy of a cell extract form Actinobacillus (Haemophilus) pleuropneumoniae serotype 1 against disease in swine. Infect. Immun. 58:358-365 (1990).
J. Devenish, S. Rosendal, and J. T. Bosse, Humoral antibody response and protective immunity in swine following immunization with the 104 kildalton hemolysin of Actinobacillus pleuropneumoniae Infect. Immuno. 58:3829-3832 (1990).
D. K. Lenser, T. L. McDonald, and N. G.Miller. Veter. Microbiol. 18:335-348 (1988).
Sanger, F., et al., PNAS 74:5463-5467 (1977).
Markmeyer, P., et al., Gene 93, 129-134 (1990).
Thwaits et al., Infection and Immunity, vol. 59, No. 2, Feb. 1991, pp. 544-549.
Young et al., Proc. Natl. Acad. Sci. USA, vol. 80, pp. 1194-1198, Mar. 1983.
Mulks et al., Abstracts of the 91st General Meeting of the American Society for Microbiology, 1991, D-230.
Mierendorf et al., Methods in Enzymology, vol. 152, 1987, pp. 458-469.
Uhlen et al., Methods in Enzymology, vol. 185, 1990, pp. 129-143.
Deneer et al., Vet. Inf. Inf. Dig. Org. Saskatoon, Saskatchewan, Canada, Microbial Pathogenesis, 1989, vol. 6, No. 6, pp. 425-432.
Cruz Maria Wilma T.
Mulks Martha H.
Thacker Brad J.
Board of Trustees operating Michigan State University
McLeod Ian C.
Scheiner Laurie
LandOfFree
43 Kd protein vaccine and method for the production thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 43 Kd protein vaccine and method for the production thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 43 Kd protein vaccine and method for the production thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-400988